Disease-specific survival following the brachytherapy management of prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 3, 2006, Pages 810-816

  Stock, Richard G ^a,b   Cesaretti, Jamie A ^a   Stone, Nelson N ^a  

^a MOUNT SINAI HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Brachytherapy; Disease specific survival; Doubling time; Prostate cancer

Indexed keywords

DISEASES; PATIENT TREATMENT; RADIOTHERAPY;

BRACHYTHERAPY; DISEASE-SPECIFIC SURVIVAL; DOUBLING TIME; PROSTATE CANCER;

TUMORS;

ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 31844440331     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.09.005     Document Type: Article

References (31)

1. G.E. Hanks, A. D'Amico, B.E. Epstein Prostatic-specific antigen doubling times in patients with prostate cancer A potentially useful reflection of tumor doubling time Int J Radiat Oncol Biol Phys 27 1993 125 127
2. A.V. D'Amico, J. Moul, P.R. Carroll Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy J Urol 172 2004 42 46
3. C.R. Pound, A.W. Partin, M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
4. Potters L, Morgenstern C, Calugaru E, et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173:1562-1566.
5. I.D. Fleming, J.S. Cooper AJCC 1992 staging system 1997 Lippincott-Raven Philadelphia
6. R.G. Stock, N.N. Stone, C. Ianuzzi Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection Implications for patient selection in the radiotherapeutic management of prostate cancer Int J Radiat Oncol Biol Phys 33 1995 815 819
7. R.G. Stock, N.N. Stone, M.F. Wesson A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation Int J Radiat Oncol Biol Phys 32 1995 219 225
8. N.N. Stone, R.G. Stock Prostate brachytherapy Treatment strategies J Urol 162 1999 421 426
9. L.N. Lee, R.G. Stock, N.N. Stone Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation Int J Radiat Oncol Biol Phys 52 2002 444 452
10. R.G. Stock, O. Cahlon, J.A. Cesaretti Combined modality treatment in the management of high-risk prostate cancer Int J Radiat Oncol Biol Phys 59 2004 1352 1359
11. R.G. Stock, N.N. Stone, A. Tabert A dose-response study for I-125 prostate implants Int J Radiat Oncol Biol Phys 41 1998 101 108
12. D. Lea, D.G. Catcheside The mechanism of the induction by radiation of chromosome aberrations in Trasdescantia J Genet 44 1942 216 245
13. G.W. Barendsen Dose fractionation, dose rate, and iso-effect relationships for normal tissue responses Int J Radiat Oncol Biol Phys 8 1982 1981 1997
14. H.D. Thames Jr, H.R. Withers, L.J. Peters Changes in early and late radiation responses with altered dose fractionation Implications for dose-survival relationships Int J Radiat Oncol Biol Phys 8 1982 219 226
15. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 62 1989 679 694
16. R.G. Dale The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy Br J Radiol 58 1985 515 528
17. D.J. Brenner, E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101
18. J. Fowler, R. Chappell, M. Ritter Is α/β for prostate cancer really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
19. M.J. Brenner, A.A. Martinez, G.K. Edmundson Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio) comparable to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
20. J.Z. Wang, M. Guerrero, X.A. Li How low is the α/β ratio for prostate cancer? Int J Radiat Oncol Biol Phys 55 2003 194 203
21. J.D. Cox, D.J. Grignon, R.S. Kaplan Consensus statement Guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
22. R.G. Stock, N.N. Stone, J. Kao The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy Implications for treatment optimization Cancer 89 2000 1829 1834
23. M.J. Norusis SPSS 10.0 guide to data analysis 2000 Prentice-Hall Upper Saddle River, NJ
24. J.E. Sylvester, J.C. Blasko, P.D. Grimm Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer The Seattle experience Int J Radiat Oncol Biol Phys 57 2003 944 952
25. L.L. Kestin, N.S. Goldstein, F.A. Vicini Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy J Urol 168 2002 1994 1999
26. M.A. Kollmeier, R.G. Stock, N. Stone Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up Importance of patient selection and implant quality Int J Radiat Oncol Biol Phys 57 2003 645 653
27. L. Potters, Y. Cao, E. Calugaru A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 50 2001 605 614
28. K. Wallner, G. Merrick, L. True 125I versus 103Pd for low-risk prostate cancer Preliminary PSA outcomes from a prospective randomized multicenter trial Int J Radiat Oncol Biol Phys 57 2003 1297 1303
29. A. Bill-Axelson, L. Holmberg, M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 2005 1977 1984
30. J. Johansson, O. Andren, S. Anderson Natural history of early localized prostate cancer JAMA 291 2004 2713 2719
31. S.A. Leibel, Z. Fuks, M. Zelefsky The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement Int J Radiat Oncol Biol Phys 28 1994 7 16